Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by James M. Leatherman
Sorafenib Combined With HER-2 Targeted Vaccination Can Promote Effective T Cell Immunity in Vivo
International Immunopharmacology
Allergy
Immunology
Pharmacology
Related publications
Interleukin 2-Diphtheria Toxin Fusion Protein Can Abolish Cell-Mediated Immunity in Vivo.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
T Cell Contact With Ia Antigens on Nonhemopoietic Cells in Vivo Can Lead to Immunity Rather Than Tolerance
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Cardiac Toxicity of HER-2 Targeted Regimens
CCL16 Enhances the CD8+ and CD4+ T Cell Reactivity to Human Her-2 Elicited by Dendritic Cells Loaded With Rat Ortholog Her-2
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
Sorafenib With Interleukin-2 vs Sorafenib Alone in Metastatic Renal Cell Carcinoma: The ROSORC Trial
British Journal of Cancer
Cancer Research
Oncology
High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote v 9V 2 T-Cell Chemotaxis and Cytotoxicity in Vivo
Cancer Research
Cancer Research
Oncology
Sustained Antigen Presentation Can Promote an Immunogenic T Cell Response, Like Dendritic Cell Activation
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
In Vivo Inhibitory Effect of Suberoylanilide Hydroxamic Acid Combined With Sorafenib on Human Hepatocellular Carcinoma Cells
Brazilian Journal of Pharmaceutical Sciences
Toxicology
Pharmaceutics
Pharmacology
CD4+ Regulatory T Cell Responses Induced by T Cell Vaccination in Patients With Multiple Sclerosis
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
